Bold
Investors
ASX
Latest News
ASX Announcements
Companies
Home
ASX Announcements
NYR Announcements
Nyrada Receives Notice of Allowance for…
NYR
NYRADA INC.
Market sensitive
Nyrada Receives Notice of Allowance for Xolatryp US Patent
Date and time
20 May 2026 at 1:10 am
Announcement type
Company Update
Show details
Hide details
Category
Other
Report codes
11001
Sector
Health Care
Industry group
Pharmaceuticals, Biotechnology & Life Sciences
View on ASX
Open original PDF
NYR announcement history
Recent NYR announcements
Xolatryp Demonstrates Cardioprotection in Preclinical Study
Nyrada Full Year Results FY2026
Annual Report for year ended 30 June 2026
Preliminary Final Report
Appendix 4G and Corporate Governance Statement
Change in substantial holding - M Azzi